Re: Circulating Kidney Injury Molecule-1 (KIM-1) and Association with Outcome to Adjuvant Immunotherapy in Renal Cell Carcinoma. // European Urology. – URL: https://www.sciencedirect.com/science/article/pii/S0302283826021834?dgcid=rss_sd_all
Re: Circulating Kidney Injury Molecule-1 (KIM-1) and Association with Outcome to Adjuvant Immunotherapy in Renal Cell Carcinoma. European Urology. https://www.sciencedirect.com/science/article/pii/S0302283826021834?dgcid=rss_sd_all
“Re: Circulating Kidney Injury Molecule-1 (KIM-1) and Association with Outcome to Adjuvant Immunotherapy in Renal Cell Carcinoma.” European Urology.
@article{article45310,
title = {Re: Circulating Kidney Injury Molecule-1 (KIM-1) and Association with Outcome to Adjuvant Immunotherapy in Renal Cell Carcinoma},
journal = {European Urology},
url = {https://www.sciencedirect.com/science/article/pii/S0302283826021834?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...